Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001994710-25-000003
Filing Date
2025-10-17
Accepted
2025-10-17 16:30:06
Documents
1
Period of Report
2025-10-15

Document Format Files

Seq Description Document Type Size
1 form4-10172025_041003.html 4  
1 form4-10172025_041003.xml 4 3336
  Complete submission text file 0001994710-25-000003.txt   4916
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Issuer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TOURMALINE BIO, INC. 27 WEST 24TH STREET, SUITE 702 NEW YORK NY 10010
Business Address
Johnson Kevin Bruce (Reporting) CIK: 0001994710 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40384 | Film No.: 251401166